BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 33959755)

  • 1. The Cholesterol Metabolite 27HC Increases Secretion of Extracellular Vesicles Which Promote Breast Cancer Progression.
    Baek AE; Krawczynska N; Das Gupta A; Dvoretskiy SV; You S; Park J; Deng YH; Sorrells JE; Smith BP; Ma L; Nelson AT; McDowell HB; Sprenger A; Henn MA; Madak-Erdogan Z; Kong H; Boppart SA; Boppart MD; Nelson ER
    Endocrinology; 2021 Jul; 162(7):. PubMed ID: 33959755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression.
    Ma L; Wang L; Nelson AT; Han C; He S; Henn MA; Menon K; Chen JJ; Baek AE; Vardanyan A; Shahoei SH; Park S; Shapiro DJ; Nanjappa SG; Nelson ER
    Cancer Lett; 2020 Nov; 493():266-283. PubMed ID: 32861706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells.
    Baek AE; Yu YA; He S; Wardell SE; Chang CY; Kwon S; Pillai RV; McDowell HB; Thompson JW; Dubois LG; Sullivan PM; Kemper JK; Gunn MD; McDonnell DP; Nelson ER
    Nat Commun; 2017 Oct; 8(1):864. PubMed ID: 29021522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol Metabolite 27-Hydroxycholesterol Enhances the Secretion of Cancer Promoting Extracellular Vesicles by a Mitochondrial ROS-Induced Impairment of Lysosomal Function.
    Das Gupta A; Park J; Sorrells JE; Kim H; Krawczynska N; Gamage HEV; Nelczyk AT; Boppart SA; Boppart MD; Nelson ER
    bioRxiv; 2024 May; ():. PubMed ID: 38746134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha.
    Umetani M; Ghosh P; Ishikawa T; Umetani J; Ahmed M; Mineo C; Shaul PW
    Cell Metab; 2014 Jul; 20(1):172-82. PubMed ID: 24954418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth.
    Wu Q; Ishikawa T; Sirianni R; Tang H; McDonald JG; Yuhanna IS; Thompson B; Girard L; Mineo C; Brekken RA; Umetani M; Euhus DM; Xie Y; Shaul PW
    Cell Rep; 2013 Nov; 5(3):637-45. PubMed ID: 24210818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology.
    Nelson ER; Wardell SE; Jasper JS; Park S; Suchindran S; Howe MK; Carver NJ; Pillai RV; Sullivan PM; Sondhi V; Umetani M; Geradts J; McDonnell DP
    Science; 2013 Nov; 342(6162):1094-8. PubMed ID: 24288332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host CYP27A1 expression is essential for ovarian cancer progression.
    He S; Ma L; Baek AE; Vardanyan A; Vembar V; Chen JJ; Nelson AT; Burdette JE; Nelson ER
    Endocr Relat Cancer; 2019 Jul; 26(7):659-675. PubMed ID: 31048561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of 27-hydroxycholesterol on endometrial cancer proliferation.
    Gibson DA; Collins F; Cousins FL; Esnal Zufiaurre A; Saunders PTK
    Endocr Relat Cancer; 2018 Apr; 25(4):381-391. PubMed ID: 29371332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Our evolving understanding of how 27-hydroxycholesterol influences cancer.
    Ma L; Cho W; Nelson ER
    Biochem Pharmacol; 2022 Feb; 196():114621. PubMed ID: 34043965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer.
    Kimbung S; Chang CY; Bendahl PO; Dubois L; Thompson JW; McDonnell DP; Borgquist S
    Endocr Relat Cancer; 2017 Jul; 24(7):339-349. PubMed ID: 28442559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator.
    DuSell CD; Umetani M; Shaul PW; Mangelsdorf DJ; McDonnell DP
    Mol Endocrinol; 2008 Jan; 22(1):65-77. PubMed ID: 17872378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis.
    DuSell CD; Nelson ER; Wang X; Abdo J; Mödder UI; Umetani M; Gesty-Palmer D; Javitt NB; Khosla S; McDonnell DP
    Endocrinology; 2010 Aug; 151(8):3675-85. PubMed ID: 20501668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer.
    Avena P; Casaburi I; Zavaglia L; Nocito MC; La Padula D; Rago V; Dong J; Thomas P; Mineo C; Sirianni R; Shaul PW
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen Receptor Beta-Mediated Modulation of Lung Cancer Cell Proliferation by 27-Hydroxycholesterol.
    Hiramitsu S; Ishikawa T; Lee WR; Khan T; Crumbley C; Khwaja N; Zamanian F; Asghari A; Sen M; Zhang Y; Hawse JR; Minna JD; Umetani M
    Front Endocrinol (Lausanne); 2018; 9():470. PubMed ID: 30190703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of reactive oxygen species in regulating 27-hydroxycholesterol-induced apoptosis of hematopoietic progenitor cells and myeloid cell lines.
    Woo SY; Lee H; Park SM; Choi HS; Kim J; Kwon M; Sohn J; Nam JH; Kim HS; Song P; Baryawno N; Kim YH; Kim K; Lee D
    Cell Death Dis; 2022 Oct; 13(10):916. PubMed ID: 36316327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-opposed inflammatory effects of 27-hydroxycholesterol are mediated via differences in estrogen signaling.
    Houben T; Bitorina AV; Oligschlaeger Y; Jeurissen ML; Rensen S; Köhler SE; Westerterp M; Lütjohann D; Theys J; Romano A; Plat J; Shiri-Sverdlov R
    J Pathol; 2020 Aug; 251(4):429-439. PubMed ID: 32472585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol and breast cancer pathophysiology.
    Nelson ER; Chang CY; McDonnell DP
    Trends Endocrinol Metab; 2014 Dec; 25(12):649-55. PubMed ID: 25458418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum-derived extracellular vesicles from breast cancer patients contribute to differential regulation of T-cell-mediated immune-escape mechanisms in breast cancer subtypes.
    Graham R; Gazinska P; Zhang B; Khiabany A; Sinha S; Alaguthurai T; Flores-Borja F; Vicencio J; Beuron F; Roxanis I; Matkowski R; Liam-Or R; Tutt A; Ng T; Al-Jamal KT; Zhou Y; Irshad S
    Front Immunol; 2023; 14():1204224. PubMed ID: 37441083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and Cancer: 27-Hydroxycholesterol, the Missing Link.
    Asghari A; Umetani M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32650428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.